Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ECM Technologies
AddedFeb 18, 2024
UpdatedJun 18, 2026
ECM Technologies

ECM Technologies

ECM Technologies: Innovating regenerative medicine with customizable, non-animal derived Designer Collagens.

HQ
Houston, TX, US
Founded
2007
Overview
Compare
Fundraising
Employees

ECM Technologies is a Texas A&M University-based startup focused on innovating regenerative medicine through customizable, non-animal derived Designer Collagens. Utilizing bacterial-derived proteins, the company designs collagens tailored with cell instructive cues for specific biomedical applications, aiming to bridge the gap between current extracellular matrix technology and available biomaterials to enhance clinical outcomes.

Key achievements include the development of genetically customizable collagens that improve regenerative medicine practices. The company has made significant strides in biomedical engineering, offering advanced solutions for tissue repair and regeneration. ECM Technologies' impact is underscored by its commitment to non-animal derived materials, setting new standards in the field.

ECM Technologies - Similar Companies

ECM Therapeutics logo

ECM Therapeutics

TissueForm logo

TissueForm

tissueforminc.com

NeXtGen Biologics logo

NeXtGen Biologics

EndoCellutions logo

EndoCellutions

endocellutions.com

Bondwell Technologies logo

Bondwell Technologies

bondwelltech.com

GeniPhys logo

GeniPhys

geniphys.com

Jellatech logo

Jellatech

jellatech.com

EternoGen logo

EternoGen

CollaMedix logo

CollaMedix

collamedixinc.com

Humabiologics logo

Humabiologics

humabiologics.com

Eqalix logo

Eqalix

eqalix.com

Tandem Repeat Technologies logo

Tandem Repeat Technologies

tandemrepeat.com

NovoThelium logo

NovoThelium

novothelium.com

Cormatrix Cardiovascular logo

Cormatrix Cardiovascular

cormatrix.com

Bucha Bio logo

Bucha Bio

rheom.com

ECM Technologies - Quick Facts

Who are ECM Technologies' competitors?

Companies similar to ECM Technologies include ECM Therapeutics, TissueForm, NeXtGen Biologics and EndoCellutions.

When was ECM Technologies founded?

ECM Technologies was founded in 2007.

Where is ECM Technologies' headquarters located?

ECM Technologies' headquarters is located in Houston, TX, US.

When was ECM Technologies' last funding round?

ECM Technologies' most recent funding round was for $5k (USD) in May 2016.

How much has ECM Technologies raised to-date?

As of May 16, 2016, ECM Technologies has raised a total of $280k (USD).

How many employees does ECM Technologies have?

ECM Technologies has 30 employees as of Feb 4, 2024.

ECM Technologies - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Customer
  • Enterprise
  • Small Business
Main Product
  • Biomaterials
  • Collagens
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified